Home
>
National Drug Code (NDC)
>
ACCURETIC
ACCURETIC - 0071-0223-23 - (QUINAPRIL HYDROCHLORIDE and HYDROCHLOROTHIAZIDE)
Drug Information of ACCURETIC
| Product NDC: | 0071-0223 |
| Proprietary Name: | ACCURETIC |
| Non Proprietary Name: | QUINAPRIL HYDROCHLORIDE and HYDROCHLOROTHIAZIDE |
| Active Ingredient(s): | 25; 20 mg/1; mg/1 & nbsp; QUINAPRIL HYDROCHLORIDE and HYDROCHLOROTHIAZIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ACCURETIC
| Product NDC: | 0071-0223 |
| Labeler Name: | Parke-Davis Div of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020125 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19991228 |
Package Information of ACCURETIC
| Package NDC: | 0071-0223-23 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0071-0223-23) |
NDC Information of ACCURETIC
| NDC Code | 0071-0223-23 |
| Proprietary Name | ACCURETIC |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0071-0223-23) |
| Product NDC | 0071-0223 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | QUINAPRIL HYDROCHLORIDE and HYDROCHLOROTHIAZIDE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19991228 |
| Marketing Category Name | NDA |
| Labeler Name | Parke-Davis Div of Pfizer Inc |
| Substance Name | HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE |
| Strength Number | 25; 20 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
